Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.

Employees

Sector

Biotechnology & Medical Research

Calendar

19/08 Earnings release - Q2 2026

More about the company

Market Cap	10Cr 1.09Cr 94.75L 87.98L 81.14L 1.53Cr 104.14Cr 1.56Cr 10Cr 4.08Cr 52Cr 4.1Cr 4.01Cr 173.93Cr	P/E 2026 *	-0.92x	P/E 2027 *	-1.25x
Enterprise Value	14Cr 1.47Cr 1.27Cr 1.18Cr 1.09Cr 2.06Cr 140.12Cr 2.09Cr 14Cr 5.49Cr 70Cr 5.51Cr 5.39Cr 234.02Cr	EV / Sales 2026 *	-	EV / Sales 2027 *	28.4x
Free-Float	89.66%	Yield 2026 *	-	Yield 2027 *	-

02/07	Lifecare Completes Production Transfer and Provides Update on Longevity Programme	CI
29/06	Lifecare Transfers Operations from Germany to Norway, UK	MT
27/06	Lifecare ASA Discontinues Operations of Lifecare Germany GmbH	CI
10/06	Lifecare Completes First Six-Month Implant Evaluation With Continued Functionality and No Adverse Biological Response	CI
15/05	Lifecare ASA, Q1 2026 Earnings Call, May 15, 2026
15/05	Lifecare ASA Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
15/05	Lifecare Q1 operating loss NOK 31.5 mln	RE
23/04	Lifecare ASA Approves Board Appointments	CI
27/03	Lifecare ASA Announces Operational Restructuring And Centralization Of Operations	CI
27/03	Lifecare ASA Announces Discontinuation of the Business Operations of Lifecare Germany GmbH	CI
26/03	Lifecare ASA to Close German Operations, Consolidate Activities Under Planned Centralization	MT
16/03	Lifecare Chief Scientific Officer to Step Down	MT
14/03	Andreas Pfützner to Step Down as Chief Scientific Officer of Lifecare ASA	CI

02/07	LIFE: Update on production transfer and longevity programme	AQ
26/06	LIFE: Operational update regarding Lifecare Germany GmbH (i.L)	PU
22/06	LIFE: Independent tissue analysis confirms no adverse tissue response after six months of implantation	AQ
12/06	Lifecare ASA: Final results following expiry of exercise period for Warrants Series 2 issued in connection with Rights Issue	PU
10/06	Lifecare ASA: Mandatory notification of trade	PU

Manager	Title	Age	Since
Joacim Holter CEO	Chief Executive Officer	50	07/09/2020
Petter Nielsen DFI	Director of Finance/CFO	-	01/04/2026
Torsten Ernst PRN	Corporate Officer/Principal	-	01/03/2024

Director	Title	Age	Since
Trine Teigland BRD	Director/Board Member	-	26/06/2020
Morten Foros Krohnstad CHM	Chairman	-	08/05/2021
Lutz Heinemann BRD	Director/Board Member	-	20/11/2020

Lifecare AS Share Price Oslo Bors

Stocks

NO0010591191

Biotechnology & Medical Research

Valuation: Lifecare AS

Latest news : Lifecare AS

Last Transcript: Lifecare AS

Analysts' recommendations: Lifecare AS

Press Releases: Lifecare AS

News in other languages: Lifecare AS

Managers and Directors: Lifecare AS

Other Biotechnology & Medical Research

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LIFECARE AS	-.--%	-4.31%	-	-	1.09Cr
LONZA GROUP AG	-0.95%	+3.39%	-0.94%	+12.15%	4.94TCr
IQVIA HOLDINGS INC.	-2.63%	+12.30%	+25.70%	+4.41%	3.91TCr
REVOLUTION MEDICINES, INC.	-1.80%	-0.80%	+403.69%	+615.14%	4.09TCr
BEONE MEDICINES AG	-2.50%	-3.95%	+3.95%	+46.12%	3.58TCr
CELLTRION, INC.	-1.74%	+8.42%	+8.85%	+48.87%	3.05TCr
ASCENDIS PHARMA A/S	-2.40%	-3.43%	-	-	1.66TCr
MEDPACE HOLDINGS, INC.	-1.66%	-5.18%	+33.48%	+125.23%	1.61TCr
ICON PUBLIC LIMITED COMPANY	-1.52%	-1.35%	-3.35%	-34.96%	1.28TCr
EUROFINS SCIENTIFIC SE	-0.09%	+3.25%	+1.84%	+9.56%	1.37TCr
Average	-1.53%	+5.78%	+59.15%	+103.31%	2.83TCr
Weighted average by Cap.	-1.77%	+6.72%	+77.15%	+129.05%

	2026 *	2027 *
Net sales	-	50L 5L 5L 4L 4L 7L 5Cr 7L 49.99L 19.57L 2.48Cr 19.66L 19.23L 8.35Cr
Net income	-8.6Cr -90.03L -78.2L -72.62L -66.97L -1.26Cr -86Cr -1.28Cr -8.6Cr -3.37Cr -43Cr -3.38Cr -3.31Cr -143.56Cr	-8.2Cr -85.85L -74.57L -69.24L -63.86L -1.2Cr -82Cr -1.22Cr -8.2Cr -3.21Cr -41Cr -3.22Cr -3.15Cr -136.88Cr
Net Debt	3.6Cr 37.69L 32.74L 30.4L 28.04L 52.81L 36Cr 53.77L 3.6Cr 1.41Cr 18Cr 1.42Cr 1.38Cr 60Cr	3.8Cr 39.78L 34.55L 32.09L 29.59L 55.74L 38Cr 56.75L 3.8Cr 1.49Cr 19Cr 1.49Cr 1.46Cr 63Cr